Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Sci. STKE, 16 October 2007
Vol. 2007, Issue 408, p. tw375
[DOI: 10.1126/stke.4082007tw375]

EDITORS' CHOICE

Apolipoprotein E Cholesterol and Alzheimer’s Disease

John F. Foley

Science’s STKE, AAAS, Washington, DC 20005, USA

The relationship between the abundance of cholesterol in the brain and Alzheimer’s disease (AD) progression is a controversial one, although cholesterol is necessary for neuronal function. Because the {varepsilon}4 allele of the gene encoding apolipoprotein E (apoE), a lipoprotein that transports cholesterol, is a genetic risk factor for late-onset AD, Liu et al. investigated a link between amyloid precursor protein (APP), apoE, and cholesterol metabolism. Sequential cleavage of APP, a transmembrane protein, by beta-secretase and {gamma}-secretase releases amyloid beta-peptide (Abeta) and the APP intracellular domain (AICD) into the extracellular space, where the former forms plaques. The authors found that the abundance of apoE (as measured by enzyme-linked immunosorbent assay) was lower in the brains of APP-deficient mice (APP-KO) and mice deficient in both APP and the related APLP2 (DKO) than in wild-type mice. Real-time polymerase chain reaction and Western blotting analyses showed that the abundance of the apoE receptor LRP1 was higher in APP-KO and DKO mice than in wild-type controls. Brain-specific deletion of LRP1 resulted in the higher abundance of apoE in the brains of these mice than in the brains of wild-type mice. Deletion of the gene encoding beta-secretase, which is required for Abeta production, had no effect on LRP1 abundance or function. However, deletion of both presenilin 1 (PS1) and PS2 (PS DKO), which encode proteins critical to the function of {gamma}-secretase, resulted in the higher abundance of LRP1 in PS DKO mice compared with that of wild-type mice. Further analysis showed that the AICD, released through {gamma}-secretase activity, combined with the adaptor protein Fe65 and bound to the LRP1 promoter, inhibiting its expression. Thus, APP processing by {gamma}-secretase results in the decreased abundance of LRP1, which results in the reduced uptake of apoE-complexed cholesterol. Together, these data suggest a role for APP in regulating apoE and cholesterol metabolism, through the lipoprotein receptor LRP1, which provides new therapeutic targets for treating AD.

Q. Liu, C. V. Zerbinatti, J. Zhang, H.-S. Hoe, B. Wang, S. L. Cole, J. Herz, L. Muglia, G. Bu, Amyloid precursor protein regulates brain apolipoprotein E and cholesterol metabolism through lipoprotein receptor LRP1. Neuron 56, 66-78 (2007). [PubMed]

Citation: J. F. Foley, Cholesterol and Alzheimer’s Disease. Sci. STKE 2007, tw375 (2007).



To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882